Aptus Drawdown Managed Equity ETFADME

The Aptus Drawdown Managed Equity ETF (ADME) started life on Nasdaq as the ticker that promised to manage drawdowns while charging for the pleasure, quietly tucking its 0.70% annual fee into quarterly deductions and its rule book into SEC EDGAR. The listing is live, the quote page is lit, and the issuer’s marketing now has a ticker to dress up in thematic spangles-equity drawdown management, rebalanced and marketed like a gym membership for portfolios that already lift more than their own weight. The Nasdaq page proves the instrument trades; the EDGAR filing proves the filing trail exists; the Fund Analyzer proves the fee is real and timeless.

ADME is a wrapper that sells “managed equity” as if the words alone can soften the next 20% drop, but the actual product is the basket, the mandate, and the 70 basis points that vanish whether the market falls or flies. The issuer’s slide deck calls it a “risk-managed equity sleeve,” which is marketing code for “we’ll try to keep the ride smoother than the fee.” The fund’s holdings and concentration sit behind the marketing slide, and the liquidity risk is whatever the secondary market decides to cough up on any given day. The wrapper’s value proposition is the theme; the fee is the only settled outcome.

The SEC EDGAR filing for ADME lists the fund’s identity and structure, but it does not list the next drawdown or the next fee waiver. The EDGAR entry confirms the wrapper, the mandate, and the expense ratio; it does not confirm the fund’s ability to relative strength a simple index while charging 0.70% per year. The filing proves the fund exists and what it charges, not what it will deliver when the S&P 500 next hiccups.

If you want the chart, Nasdaq’s ADME page is the cleanest route; the market mechanism is the wrapper, the fee, and the investor’s willingness to pay for a theme that promises to cushion falls without guaranteeing to cushion fees. The issuer’s marketing sells the dream; the EDGAR filing sells the receipt; the Fund Analyzer calculates the cost. None of these sources proves the fund will stop the next drawdown-only that it will charge you while trying. The joke isn’t on the investor; it’s on the wrapper that markets a mandate while billing for the privilege of watching the mandate play out.

What changed today? The Nasdaq page updates intraday volume and price, but the fund’s holdings, mandate, and fee remain static unless the issuer files an update. The EDGAR filing hasn’t changed since inception unless a new N-PORT or N-CEN drops, and the Fund Analyzer recalculates costs based on the latest fee schedule, not the market’s mood. The wrapper’s liquidity is whatever the secondary market supplies, and the concentration risk sits in the top holdings the issuer discloses on its product page-if you can find it buried under the thematic frosting.

What remains unproven: the fund’s ability to cushion the next drawdown; the next fee waiver; the next rebalancing cadence beyond the issuer’s quarterly disclosure. Evidence that would deepen the file includes an updated EDGAR filing with holdings and concentration, a product page with the top ten holdings and their weights, and a live chart with volume and spreads that reflect the wrapper’s actual liquidity, not just the ticker’s quote. The Nasdaq page is the cleanest route, but it proves only that the wrapper trades, not that it works.